YIH
OCEA

Y-Intercept (HK)’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Y-Intercept (HK)’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,300
Closed -$29.6K – 1903
2024
Q2 		$29.6K Buy
+24,300
New +$41.5K ﹤0.01% 1316

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Y-Intercept (HK)'s OCEA Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q3 2024, closing a stake of 24,300 shares — an estimated $29.6K sold.

Y-Intercept (HK) first reported a position in OCEA in Q2 2024 and held it in 1 quarter. The position peaked at $29.6K in Q2 2024. 21 funds tracked by Wall St. Rank hold OCEA as of Q3 2024.

  • Y-Intercept (HK) reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 24,300 Ocean Biomedical, Inc. Common Stock shares in Q3 2024, an estimated $29.6K.
  • Y-Intercept (HK) first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Y-Intercept (HK)'s Ocean Biomedical, Inc. Common Stock position peaked at $29.6K in Q2 2024.
  • 21 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.